These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 19147771)

  • 1. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
    Macher-Goeppinger S; Aulmann S; Tagscherer KE; Wagener N; Haferkamp A; Penzel R; Brauckhoff A; Hohenfellner M; Sykora J; Walczak H; Teh BT; Autschbach F; Herpel E; Schirmacher P; Roth W
    Clin Cancer Res; 2009 Jan; 15(2):650-9. PubMed ID: 19147771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.
    McCarthy MM; Sznol M; DiVito KA; Camp RL; Rimm DL; Kluger HM
    Clin Cancer Res; 2005 Jul; 11(14):5188-94. PubMed ID: 16033835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
    Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T
    Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
    Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of TRAIL and its death receptors in cervical cancer.
    Maduro JH; Noordhuis MG; ten Hoor KA; Pras E; Arts HJ; Eijsink JJ; Hollema H; Mom CH; de Jong S; de Vries EG; de Bock GH; van der Zee AG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):203-11. PubMed ID: 19695437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.
    Horak P; Pils D; Kaider A; Pinter A; Elandt K; Sax C; Zielinski CC; Horvat R; Zeillinger R; Reinthaller A; Krainer M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8585-91. PubMed ID: 16361541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas.
    Macher-Goeppinger S; Bermejo JL; Wagener N; Hohenfellner M; Haferkamp A; Schirmacher P; Roth W
    Cancer Lett; 2011 Feb; 301(2):203-11. PubMed ID: 21196076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients.
    Ullenhag GJ; Mukherjee A; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    Clin Cancer Res; 2007 Sep; 13(17):5070-5. PubMed ID: 17785559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
    Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.
    Manzo F; Nebbioso A; Miceli M; Conte M; De Bellis F; Carafa V; Franci G; Tambaro FP; Altucci L
    Int J Biochem Cell Biol; 2009 Mar; 41(3):460-6. PubMed ID: 18243765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma.
    Campbell L; Nuttall R; Griffiths D; Gumbleton M
    Cancer; 2009 Aug; 115(15):3457-67. PubMed ID: 19526593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
    Cross SS; Harrison RF; Balasubramanian SP; Lippitt JM; Evans CA; Reed MW; Holen I
    J Clin Pathol; 2006 Jul; 59(7):716-20. PubMed ID: 16489180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas.
    Sanlioglu AD; Dirice E; Elpek O; Korcum AF; Balci MK; Omer A; Griffith TS; Sanlioglu S
    Pancreas; 2008 May; 36(4):385-93. PubMed ID: 18437085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
    Mignogna C; Staibano S; Altieri V; De Rosa G; Pannone G; Santoro A; Zamparese R; D'Armiento M; Rocchetti R; Mezza E; Nasti M; Strazzullo V; Montanaro V; Mascolo M; Bufo P
    BMC Cancer; 2006 Dec; 6():293. PubMed ID: 17177989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival.
    Lancaster JM; Sayer R; Blanchette C; Calingaert B; Whitaker R; Schildkraut J; Marks J; Berchuck A
    Clin Cancer Res; 2003 Feb; 9(2):762-6. PubMed ID: 12576447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
    Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
    Zhang Y; Zhang B
    Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.